Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Weight Loss × Exenatide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 5 Obesity 5 Sexual Infantilism 4 Craniopharyngioma 3 Overweight 2 Weight Loss 1 Pancreatic Neoplasms 1 Insulin Resistance 1 Fatty Liver 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus, Type 1 1

Interventions

Exercise 6 Diet 5 Octreotide 3 Metformin 3 Caloric Restriction 3 Diet, Carbohydrate-Restricted 2 Cognitive Behavioral Therapy 2 sibutramine 1 remune 1 olanzapine-fluoxetine combination 1 irinotecan sucrosofate 1 bermekimab 1 Weight Reduction Programs 1 Surveys and Questionnaires 1 Sugars 1 Standard of Care 1 Sampling Studies 1 Ritonavir 1 Resistance Training 1 Quality of Life 1 Psychology, Positive 1 Palonosetron 1 Palliative Care 1 Olanzapine 1 Nutritionists 1 Nutrition Assessment 1 Methods 1 Melatonin 1 Liraglutide 1 Inositol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02664441 2022-05-05

ECHO

Seattle Children's Hospital

Phase 3 Completed

42 enrolled 26 charts

Obesity, Weight Loss, Sexual Infantilism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡